Penetration of ceftriaxone one into the middle ear fluid of children

Pediatric Infectious Disease Journal

Volumn 17, Issue 3, 1998, Pages 258-260

  Gudnason, Thorolfur ^a   Gudbrandsson, Fridrik ^b   Barsanti, Franco ^b   Kristinsson, Karl G ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b NONE

Author keywords

Ceftriaxone; Children; Middle ear fluid; Otitis media

Indexed keywords

AMOXICILLIN; CEFTRIAXONE;

ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG PENETRATION; FEMALE; HUMAN; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE EAR MUCOSA; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AREA UNDER CURVE; CEFTRIAXONE; CEPHALOSPORINS; CHILD, PRESCHOOL; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; INFANT; MALE; OTITIS MEDIA WITH EFFUSION;

EID: 0031945431     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199803000-00022     Document Type: Article

References (17)

1. Knapp CC, Sierra-Madero J, Washington JA. Antibacterial activities of cefpodoxime, cefixime and ceftriaxone. Antimicrob Agents Chemother 1988;32:1896-8.
2. Schaad UB, Stoeckel K. Single-dose pharmacokinetics of ceftriaxone in infants and young children. Antimicrob Agents Chemother 1986;21:248-53.
3. Klein JO. Otitis media. Clin Infect Dis 1994;19:823-33.
4. Varsano I, Frydman M, Amir J, Alpert G. Single intramuscular dose of ceftriaxone compared to 7-day amoxicillin therapy for acute otitis media in children. Chemotherapy 1988; 34(Suppl 1):39-46.
5. Chamberlain JM, Oschenschlager DW, Boenning DA, Klein BL. Single-dose ceftriaxone for the treatment of acute otitis media with effusion. Am J Dis Child 1992;146:470.
6. Green SM, Rothrock SG. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics 1993;91:23-30.
7. Chamberlain JM, Boenning DA, Waisman Y, et al. Single-dose ceftriaxone versus 10 days of cefaclor for otitis media. Clin Pediatr 1994;33:642-6.
8. Howie V, Owen M, Pohl J. Bacteriologic and clinical efficacy of ceftriaxone in the treatment of otitis media. J Invest Med 1995;43(Suppl 1):16A.
9. Barnett ED, Teele DW, Klein JO, Cabral HJ, Kharasch SJ. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Pediatrics 1997;99:23-8.
10. Fraschini F, Braga PC, Scarpazza G, et al. Human pharmacokinetics and distribution in various tissues of ceftriaxone. Chemotherapy 1986;32:192-9.
11. Granich GG, Krogstad DJ. Ion pair high-performance liquid chromatographic assay for ceftriaxone. Antimicrob Agents Chemotherapy 1987;31:385-8.
12. Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: The "Pollyanna phenomenon." J Pediatr 1992; 120:72-7.
13. Rosenfeld KM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr 1994;124:355-67.
14. Canafax DM, Giebink GS. Clinical and pharmacokinetic basis for the antimicrobial treatment of acute otitis media. Otolaryngol Clin North Am 1991;24:859-75.
15. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996;15: 255-9.
16. Ingvarsson L, Kamme C, Lundgren K. Concentration of penicillin-V in serum and middle ear exudate during treatment of acute otitis media. Ann Otol Rhinol Laryngol 1980; Suppl. 89:275-7.
17. Gudnason T, Sigurdardottir LY, Kristinsson KG, Kristjánsson K, Laxdal T. One dose ceftriaxone treatment of otitis media caused by multi-resistant pneumococci. [Abstract L024]. Presented at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, September 15 to 18, 1996.